Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Erhan Ararat

Concepts (115)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Metformin
2
2025
84
1.550
Why?
Asthma
3
2025
319
1.430
Why?
Adrenal Cortex Hormones
2
2025
116
1.040
Why?
Breast Neoplasms
11
2015
1223
1.000
Why?
Organoids
2
2022
41
0.870
Why?
Hypoglycemic Agents
1
2025
227
0.780
Why?
Anti-Asthmatic Agents
1
2023
34
0.780
Why?
Lung
3
2022
481
0.670
Why?
Aspirin
2
2011
123
0.590
Why?
Diabetes Mellitus, Type 2
1
2025
591
0.580
Why?
Cystic Fibrosis
1
2021
155
0.570
Why?
Diabetes Mellitus
1
2021
321
0.520
Why?
Neoadjuvant Therapy
3
2013
124
0.410
Why?
Adolescent
6
2025
6912
0.390
Why?
Child
5
2025
7384
0.360
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2011
1043
0.320
Why?
Imidazoles
1
2010
114
0.300
Why?
Diphosphonates
1
2010
92
0.300
Why?
Neoplasm Metastasis
1
2010
237
0.300
Why?
Protein Phosphatase 1
1
2009
6
0.290
Why?
Losartan
1
2009
27
0.290
Why?
Mitogen-Activated Protein Kinase 3
1
2009
46
0.290
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2010
124
0.290
Why?
Mitogen-Activated Protein Kinase 1
1
2009
47
0.290
Why?
Angiotensin II Type 1 Receptor Blockers
1
2009
44
0.290
Why?
Isoenzymes
1
2009
165
0.280
Why?
MAP Kinase Signaling System
1
2009
127
0.280
Why?
Humans
21
2025
53246
0.270
Why?
Genetic Predisposition to Disease
1
2011
533
0.270
Why?
Female
16
2025
28792
0.240
Why?
Antineoplastic Agents
2
2011
1232
0.230
Why?
Propensity Score
1
2025
170
0.210
Why?
Allergy and Immunology
1
2024
19
0.210
Why?
Preoperative Care
1
2024
173
0.190
Why?
Blood Glucose
1
2025
491
0.190
Why?
Home Care Services
1
2023
72
0.190
Why?
Spinocerebellar Ataxias
1
2022
6
0.180
Why?
Medicaid
1
2024
294
0.170
Why?
Body Height
1
2021
68
0.170
Why?
Young Adult
4
2023
4514
0.170
Why?
Respiration, Artificial
1
2023
293
0.170
Why?
Mass Screening
1
2024
362
0.160
Why?
Disease Progression
1
2023
880
0.160
Why?
Anthracyclines
2
2011
35
0.160
Why?
Nutritional Status
1
2021
148
0.160
Why?
Male
6
2025
27444
0.150
Why?
Incidence
2
2011
1085
0.130
Why?
Child, Preschool
2
2024
4164
0.120
Why?
Retrospective Studies
4
2024
6821
0.120
Why?
Multiple Myeloma
1
2010
3082
0.120
Why?
Adult
5
2023
14541
0.120
Why?
Muscular Dystrophy, Duchenne
1
2015
32
0.110
Why?
Receptors, Progesterone
2
2013
68
0.100
Why?
Receptor, erbB-2
2
2013
79
0.100
Why?
Cardiomyopathies
1
2015
120
0.100
Why?
Receptors, Estrogen
2
2013
134
0.100
Why?
Axilla
1
2013
92
0.100
Why?
Prognosis
3
2015
2118
0.090
Why?
Heart
1
2015
350
0.090
Why?
Lymphatic Metastasis
1
2013
211
0.090
Why?
Phenotype
1
2015
803
0.090
Why?
Survival Rate
2
2013
949
0.090
Why?
Dacarbazine
1
2011
11
0.090
Why?
Lymph Nodes
1
2013
252
0.080
Why?
Opportunistic Infections
1
2011
56
0.080
Why?
Deoxycytidine
1
2011
26
0.080
Why?
Antineoplastic Agents, Alkylating
1
2011
78
0.080
Why?
Fluorouracil
1
2011
59
0.080
Why?
Genes, BRCA1
1
2011
19
0.080
Why?
Phthalazines
1
2011
20
0.080
Why?
Drugs, Generic
1
2010
9
0.080
Why?
Neoplasm Recurrence, Local
2
2013
647
0.080
Why?
Taxoids
1
2010
38
0.080
Why?
Tamoxifen
1
2010
60
0.080
Why?
Antineoplastic Agents, Hormonal
1
2010
56
0.080
Why?
Piperazines
1
2011
125
0.080
Why?
Captopril
1
2009
13
0.070
Why?
p38 Mitogen-Activated Protein Kinases
1
2009
92
0.070
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2009
73
0.070
Why?
Chemotherapy, Adjuvant
3
2015
122
0.070
Why?
Enzyme Activation
1
2009
267
0.070
Why?
Muscle, Smooth, Vascular
1
2009
135
0.070
Why?
Aorta
1
2009
172
0.070
Why?
Ventricular Function, Left
1
2009
178
0.070
Why?
Age Factors
1
2011
1136
0.070
Why?
Follow-Up Studies
1
2011
2318
0.060
Why?
Rats, Sprague-Dawley
1
2009
1544
0.060
Why?
Apoptosis
1
2010
1139
0.060
Why?
Myocardial Infarction
1
2009
445
0.050
Why?
Mutation
1
2011
1338
0.050
Why?
Treatment Outcome
2
2013
5597
0.050
Why?
Respiration
1
2023
94
0.050
Why?
Heart Failure
1
2009
531
0.050
Why?
Rats
1
2009
3164
0.050
Why?
Tracheostomy
1
2023
76
0.050
Why?
Animals
2
2022
13528
0.040
Why?
Stem Cells
1
2022
189
0.040
Why?
Epithelial Cells
1
2022
218
0.040
Why?
Emergency Service, Hospital
1
2024
530
0.040
Why?
Hospitalization
1
2024
749
0.040
Why?
Cell Differentiation
1
2022
681
0.040
Why?
Arkansas
1
2024
2068
0.040
Why?
Infant
1
2024
3808
0.030
Why?
Respiratory Function Tests
1
2015
89
0.030
Why?
Aged
3
2013
10430
0.030
Why?
United States
1
2024
5413
0.020
Why?
Neoplasm Invasiveness
1
2013
281
0.020
Why?
Disease-Free Survival
1
2013
466
0.020
Why?
Mice
1
2022
5982
0.020
Why?
Chemistry, Pharmaceutical
1
2010
35
0.020
Why?
Arthralgia
1
2010
44
0.020
Why?
Drug Administration Schedule
1
2010
370
0.020
Why?
Middle Aged
2
2013
13422
0.020
Why?
Risk Factors
1
2015
4018
0.020
Why?
Aged, 80 and over
1
2013
3495
0.010
Why?
Ararat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description